Three Top Tips for Optimising Physical Form Selection
Add bookmark
Three Top Tips for Optimising Physical Form Selection
Add bookmark
What strategies are pharmaceutical companies employing to accelerate early development and preformulation? Michael Mitchell, Head of Pharmaceutical Sciences Oss, Merck, speaks to Andrea Charles from Pharma IQ, about current preformulation strategies and outsourcing early formulation development work. Mitchell also discusses the role of risk management and the potential risks and benefits of early form selection. He also shares his insights on how active collaboration with discovery can improve the dug-ability.
[inlinead]
Tags:
Michael Mitchell
Merck
preformulation
Formulation
early formulation
formulation development
Risk Management
dug-ability
early form selection
